Cell MedX Corp. (CMXC) Research

Cell MedX Corp. is a biotechnology firm dedicated to identifying, developing, and marketing both therapeutic and non-therapeutic solutions aimed at individuals suffering from conditions such as diabetes, Parkinson's disease, hypertension, neuropathy, and various kidney-related ailments. The company's offerings include the eBalance Pro System, designed for clinical application by medical professionals, and the eBalance Home System, intended for personal use to promote general well-being and alleviate pain. Both systems are managed by the eBalance Console, a central control unit featuring three distinct pre-programmed microcurrent algorithms: wellness, pain management, and a dual mode. Originally established in 2010 as Sports Asylum, Inc., the company adopted its current name, Cell MedX Corp., in September 2014. Its operations are headquartered in Carson City, Nevada.

Market snapshot

Symbol
CMXC
Price
$0.43
Market cap
$7.4M
P/E ratio
-8.26x
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Anteris Technologies Ltd (AMEUF)
  • Broncus Holding Corporation (BRNHF)
  • Carmat S.A. (CKMTF)
  • China Medical & HealthCare Group Limited (COLRF)
  • Creso Pharma Limited (COPHF)
  • Green Rain Energy Holdings Inc. (GREH)
  • Japan Medical Dynamic Marketing, Inc. (JMDMF)
  • Leafly Holdings, Inc. (LFLY)

Open Cell MedX Corp. (CMXC) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.